Related Experiment Video
Updated: Jun 15, 2026

The Dyspepsia Educational Tool As a Novel Aid in Dyspepsia Management
Published on: June 29, 2019
Dyspepsia, peptic ulcer, and H. pylori: a remembrance of things past
Abstract:
Dyspepsia and gastroesophageal reflux disease are common conditions in clinical practice. Current management strategies emphasize testing and treatment for Helicobacter pylori in the initial management of patients presenting with dyspeptic symptoms in regions where the prevalence of H. pylori infection is >15%. Population-based studies in patients with dyspepsia suggest that peptic ulcer disease related to H. pylori infection is decreasing in prevalence, whereas gastroesophageal reflux disease is becoming a more common cause of dyspeptic symptoms. Unfortunately, symptoms are a poor predictor of endoscopic findings, and alarm features are not a good predictor of an underlying malignancy. Although peptic ulcer disease has declined in Western countries, specific populations such as immigrants and rural communities may have a high prevalence of infection and peptic ulcer disease that needs to be considered in initial dyspepsia management, even in areas where the general prevalence of H. pylori infection has declined below 15%.
Related Concept Videos
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Peptic Ulcer Disease I: Introduction
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
Peptic Ulcer Disease I: Introduction
Peptic Ulcer Disease III: Clinical Manifestations and Complications
Peptic Ulcer Disease II: Pathophysiology
Peptic Ulcer Disease II: Pathophysiology
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
